AU1572101A - Admixture of linezolid and other antibacterial agents - Google Patents

Admixture of linezolid and other antibacterial agents

Info

Publication number
AU1572101A
AU1572101A AU15721/01A AU1572101A AU1572101A AU 1572101 A AU1572101 A AU 1572101A AU 15721/01 A AU15721/01 A AU 15721/01A AU 1572101 A AU1572101 A AU 1572101A AU 1572101 A AU1572101 A AU 1572101A
Authority
AU
Australia
Prior art keywords
linezolid
admixture
antibacterial agents
antibacterial
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15721/01A
Inventor
Donald H. Batts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of AU1572101A publication Critical patent/AU1572101A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU15721/01A 1999-11-08 2000-11-02 Admixture of linezolid and other antibacterial agents Abandoned AU1572101A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16399099P 1999-11-08 1999-11-08
US60163990 1999-11-08
PCT/US2000/028872 WO2001034128A2 (en) 1999-11-08 2000-11-02 Admixture for intravenous administration of linezolid and other antibacterial agents

Publications (1)

Publication Number Publication Date
AU1572101A true AU1572101A (en) 2001-06-06

Family

ID=22592515

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15721/01A Abandoned AU1572101A (en) 1999-11-08 2000-11-02 Admixture of linezolid and other antibacterial agents

Country Status (5)

Country Link
AU (1) AU1572101A (en)
CO (1) CO5251446A1 (en)
EC (1) ECSP003756A (en)
PE (1) PE20011006A1 (en)
WO (1) WO2001034128A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY127336A (en) * 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
PE20020044A1 (en) 2000-06-16 2002-01-30 Upjohn Co THIAZINE OXAZOLIDINONE
WO2004052333A1 (en) * 2002-12-11 2004-06-24 Pari Gmbh Pharmaceutical compositions for the pulmonary delivery of aztreonam
CA2733145C (en) 2003-07-02 2012-06-19 Corus Pharma, Inc. Aztreonam l-lysine and method of determining impurities therein
AU2005315140B2 (en) 2004-12-17 2010-05-27 Venus Remedies Limited Antibiotic combinations for providing total solution to the treatment of infections
WO2007086014A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefpirome, tazobactam and linezolid
WO2007086011A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising cefepime, tazobactam and linezolid
WO2007086013A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation comprising of ceftazidime, tazobactam and linezolid
WO2007086012A1 (en) * 2006-01-25 2007-08-02 Jegannathan Srinivas Formulation of cefpodoxime, clavulanic acid and linezolid
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
CN102643251B (en) * 2012-04-17 2016-08-10 四川美大康佳乐药业有限公司 degradation impurity of linezolid and preparation method thereof
CN102973500A (en) * 2012-12-25 2013-03-20 江苏吴中苏药医药开发有限责任公司 Linezolid liquid preparation and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials

Also Published As

Publication number Publication date
PE20011006A1 (en) 2001-09-14
WO2001034128A3 (en) 2001-11-22
CO5251446A1 (en) 2003-02-28
WO2001034128A2 (en) 2001-05-17
ECSP003756A (en) 2002-05-23

Similar Documents

Publication Publication Date Title
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001286878A1 (en) Oxazolidinones and their use as antibacterial agents
AU3587900A (en) Use of 5-aminosalicylates as antimicrobial agents
AU1315797A (en) Piperazinonephenyloxazolidinone derivatives and their use as antibacterial agents
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
AU3620600A (en) Skin-marking devices and their use
AU4658100A (en) Skin-friendly absorbent articles and compositions
AU4923200A (en) Isothiazolecarboxamides and their use as microbicides
AU1164601A (en) Therapeutic use and formulation
AU1403501A (en) Novel composition and use
AU1572101A (en) Admixture of linezolid and other antibacterial agents
AU1969800A (en) Combination of active agents
AU5029700A (en) Glycopeptide antibacterial compounds, compositions containing same and methods of using same
AU1152601A (en) Compositions and their use
AU7598000A (en) Antimicrobial topical composition and methods
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
EP1011689B8 (en) USE OF 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
AU1911301A (en) Novel bacterial isolate and the preparation and use of its active metabolites
AU2742799A (en) Voacamine as anti-malarial agent and anti-malarial agent containing voacamine
AU1301699A (en) Use of granulysin as an antimicrobial agent
AU6102899A (en) Production and use of antimicrobial agents
AU3760900A (en) Treatment of menstrual function
AU3716800A (en) Placemat having antimicrobial agent
HUP0003845A3 (en) Use of 8a-azalides as antimicrobial agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase